NCI Community Oncology Research Program (NCORP) Community Sites

NCI 社区肿瘤学研究计划 (NCORP) 社区网站

基本信息

批准号：
8901094
负责人：
Albert DeNittis
金额：
$ 62.7万
依托单位：
LANKENAU INSTITUTE FOR MEDICAL RESEARCH
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-08-01 至 2019-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8901094
关键词：
Address Area Cancer Patient Cancer Research Infrastructure Cancer and Leukemia Group B Caring Clinical Clinical Research Clinical Trials Communities Community Clinical Oncology Program Community Physician Continuity of Patient Care County Delaware Development Diagnosis Eastern Cooperative Oncology Group Effectiveness Enrollment Ensure Environment Goals Gynecologic Oncology Group Health Health system Healthcare Institutes Knowledge Laboratories Leadership Learning Malignant Neoplasms Medical Medical center Medicine National Surgical Adjuvant Breast and Bowel Project Organizational Models Outcome Patients Pennsylvania Performance Personal Satisfaction Philadelphia Physicians Population Prevention Process Quality of Care Quality of life Radiation Therapy Oncology Group Reporting Research Research Infrastructure Services Site Time Translating Universities base cancer care cancer diagnosis cancer prevention cancer therapy care delivery cost forest improved insight multidisciplinary programs screening

项目摘要

DESCRIPTION (provided by applicant): Main Line Health has access to nearly 1 million people and its service area includes Western Philadelphia, Montgomery, Chester and Delaware Counties of Pennsylvania. Annually, MLH provides care for ~ 3100 new cancer cases, of which approximately 50% of patients are 65 years or older. Main Line Health (MLH) has participated as a NCI CCOP for the past 20 years and has the infrastructure in place to become a NCORP Community Site, Strengthening this infrastructure, MLH is transitioning to a "One Program, Multiple Sites" cancer care organizational model where oversight by a single service line leadership team (clinical and administrative) is accountable for service line performance. Main Line Health long-term goals include: continue to provide state of the art multidisciplinary treatment that improves outcomes and quality of life for our patients; identify and address disparities of care and advancing standards of care. To accomplish these goals, MLH NCORP will continue providing access to NCI-approved clinical trials for cancer prevention, control, screening and treatment. Additionally, MLH NCORP will educate healthcare colleagues and patients about the importance and impact of clinical trials, helping to reduce barriers to accrual MLH will evaluate its cancer care processes, learning what factors outside of a patient's cancer diagnosis may create barriers or impact a patient's well-being. Although Main Line Health does have internal assessment in place, as a NCORP Community site, MLH will be able to evaluate its cancer care and services on a larger scale and report these findings to the physician and patient community and transform care. Main Line Health's existing relationships with the following Research Bases: CALGB (Alliance), ECOG, GOG, IVID Anderson, NSABP, RTOG, and Wake Forest University, help ensure a study portfolio complementary of MLH cancer population and access to important cancer care delivery questions.

描述（由申请人提供）：主线健康已有近100万人，其服务领域包括宾夕法尼亚州西部费城，蒙哥马利，切斯特和特拉华州县。每年，MLH为约3100例新癌症病例提供护理，其中约50％的患者年龄在65岁以上。在过去的20年中，Main Line Health（MLH）已担任NCI CCOP，并拥有基础架构成为NCORP社区网站，增强了这种基础设施，MLH正在过渡到“一个程序，多个网站”癌症护理组织模型，其中单个服务线领导团队（临床和管理）的监督负责。主线健康长期目标包括：继续提供最先进的多学科治疗状态，从而改善了我们的患者的结局和生活质量；识别和解决护理和促进护理标准的差异。为了实现这些目标，MLH NCORP将继续提供NCI批准的临床试验，以预防癌症，对照，筛查和治疗。此外，MLH NCORP将教育医疗保健同事和患者有关临床试验的重要性和影响，有助于减少应计MLH的障碍，将评估其癌症护理过程，学习以外的癌症诊断以外的因素可能会造成障碍或影响患者的健康状况。尽管主线健康确实具有内部评估，作为NCORP社区网站，MLH将能够更大范围地评估其癌症护理和服务，并将这些发现报告给医师和患者社区并转变护理。 Main Line Health与以下研究基础的现有关系：CALGB（联盟），ECOG，GOG，Ivid Anderson，NSABP，RTOG和Wake Forest University，有助于确保研究组合的MLH癌症人群的补充，并获得重要的癌症护理提供问题。